Trade

Dr Agarwal's Eye Hospital share price

Balanced risk
  • 25%Low risk
  • 25%Moderate risk
  • 25%Balanced risk
  • 25%High risk
  • 25%Extreme risk
  • 4,840.00(-0.88%)
    April 22, 2026 14:23:46 PM IST
    • NSE
    • BSE
  • Vol : 0.38 K (NSE + BSE)
    Last 20 day avg : 1.24 K

Dr Agarwal's Eye Hospital is trading -0.88% lower at Rs 4,840.00 as compared to its last closing price. Dr Agarwal's Eye Hospital has been trading in the price range of 4,881.00 & 4,740.60. There are 2 analysts who have initiated coverage on Dr Agarwal's Eye Hospital. There are 0.00 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 17.28 Crores in its last quarter.Listed peers of Dr Agarwal's Eye Hospital include Global Health (2.66%), Max Healthcare Institute (-1.39%), Fortis Healthcare (0.82%).The Mutual Fund holding in Dr Agarwal's Eye Hospital was at 0.03% in 31 Mar 2026. The MF holding has decreased from the last quarter. The FII holding in Dr Agarwal's Eye Hospital was at 2.20% in 31 Mar 2026. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Apr 22, 2026, 09:04 AM UTC

  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    1.59
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.14
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    1.03
    Indicates Fair Valuation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -
Price range
Day Range
Lowest
4,740.60
Highest
4,881.00
52 week range
Lowest
3,866.90
Highest
6,392.00
Dr Agarwal's Eye Hospital Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Global Health
Neutral
1,111.102.6629,958.0361.739.450.0418.41
Max Healthcare Institute
Neutral
1,007.35-1.3998,154.6593.4311.210.1429.50
Fortis Healthcare
Bullish
924.100.8269,761.8880.047.640.1125.92
Apollo Hospitals Enterprise
Bullish
7,676.00-0.881,10,338.4771.0912.560.2683.18
Narayana Hrudayalaya
Neutral
1,811.150.4236,986.1447.6610.510.2459.03
Mutual Fund Ownership
View all
WhiteOak Capital Pharma and Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 1.99
  • % of AUM 0.60
PGIM India Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 0.26
  • % of AUM 0.23
PGIM India Retirement Fund Regular Growth
NA
  • Amount Invested (Cr.) 0.19
  • % of AUM 0.22
Dr Agarwal's Eye Hospital Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-02-03Quarterly Results
2025-10-30Quarterly Results & Interim Dividend
2025-08-27Preferential Issue of shares
2025-08-12Quarterly Results
2025-05-28Audited Results & Final Dividend
About the company Dr Agarwal's Eye Hospital
  • IndustryHealthcare Facilities
  • ISININE934C01018
  • BSE Code526783
  • NSE Code
Dr. Agarwal's Eye Hospital Limited is an India-based company engaged in running, owning and managing eye care hospitals, optical, pharmacies, and related services. The Company provides eye anatomy & treatments, including retina, uvea, cornea, orbit, photocoagulation, vitrectomy, anti VEGF, dry eyes, scleral buckle, pre descemets endothelial keratoplasty (PDEK), refractive surgery and pediatric ophthalmology. It also provides treatment for cataract, glaucoma, squint, diabetic retinopathy, retinal detachment, retinopathy prematurity, macular edema, traumatic cataract, macular hole, posterior subcapsular cataract, rosette cataract and congenital glaucoma. The Company provides its services in various locations in India, including Tamil Nadu, Karnataka, Maharashtra, Kerala, West Bengal, Odisha, Andhra Pradesh, Pondicherry, Gujarat, Rajasthan, Madhya Pradesh, and Andaman.
  • Management Info
  • Amar AgarwalExecutive and Non-Independent Chairman of the Board, Managing Director
  • Yashwanth VenkatInterim Chief Financial Officer
  • Meenakshi JayaramanCompliance Officer, Company Secretary
  • Saradha GovindarajanCompliance Officer
  • Athiya AgarwalNon-Independent Whole Time Director
  • S. Lakshmi NarasimhanCompany Secretary
Dr Agarwal's Eye Hospital Share Price FAQs

Dr Agarwal's Eye Hospital is trading at 4840.00 as on Wed Apr 22 2026 08:53:46. This is -0.88% lower as compared to its previous closing price of 4882.80.

The market capitalization of Dr Agarwal's Eye Hospital is 2318.60 Cr as on Wed Apr 22 2026 08:53:46.

The average broker rating on Dr Agarwal's Eye Hospital is Buy. The breakup of analyst rating is given below -

  • 0.00 analysts have given a strong buy rating
  • 1 analysts have given a buy rating
  • 1 analysts have given a hold rating
  • 0.00 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Dr Agarwal's Eye Hospital is 6392.00 whereas the 52 wk low is 3866.90

Dr Agarwal's Eye Hospital can be analyzed on the following key metrics -

  • TTM P/E:
  • Sector P/E: 30.69
  • Dividend Yield: 0.13%
  • D/E ratio: -

Dr Agarwal's Eye Hospital reported a net profit of 54.65 Cr in 2025.

The Mutual Fund Shareholding was 0.03% at the end of 31 Mar 2026.